Download PDF
Thromb Haemost 1996; 75(03): 445-449
DOI: 10.1055/s-0038-1650294
Original Article
Schattauer GmbH Stuttgart

Factor XIa Induced Activation of the Intrinsic Cascade In Vivo

Hugo ten Cate
1   The Dept. of Internal Medicine, Slotervaartziekenhuis, Amsterdam, The Netherlands
2   The Center for Hemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, Amsterdam, The Netherlands
,
Bart J Biemond
2   The Center for Hemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, Amsterdam, The Netherlands
3   Dept. of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
,
Marcel Levi
2   The Center for Hemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, Amsterdam, The Netherlands
3   Dept. of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
,
Walter A Wuillemin
4   Central Laboratory of the Netherlands Red Cross Bloodtransfusion Service, Amsterdam, The Netherlands
,
Kenneth Bauer
5   Department of Medicine, Beth Israel Hospital, Amsterdam, The Netherlands
6   Brockton - West Roxbury Department of Veterans Affairs Medical Center, Harvard Medical School, Boston, Massachusetts, USA
,
Samad Barzegar
5   Department of Medicine, Beth Israel Hospital, Amsterdam, The Netherlands
,
Harry R Buller
1   The Dept. of Internal Medicine, Slotervaartziekenhuis, Amsterdam, The Netherlands
,
C Erik Hack
1   The Dept. of Internal Medicine, Slotervaartziekenhuis, Amsterdam, The Netherlands
,
Jan W ten Cate
2   The Center for Hemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, Amsterdam, The Netherlands
,
Robert D Rosenberg
5   Department of Medicine, Beth Israel Hospital, Amsterdam, The Netherlands
7   The Department of Biology and Whitaker College of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
› Author Affiliations
Further Information

Publication History

Received 26 June 1995

Accepted after resubmission 28 November 1995

Publication Date:
31 August 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Coagulation factor XI is a glycoprotein of the contact factor system. Its deficiency is associated with a highly variable bleeding tendency, thus a role in relation to hemostasis appears to exist. However, the importance of factor XI for stimulating intrinsic coagulation in vivo has not yet been determined. To study the procoagulant effects of human factor Xla in vivo, we infused the purified enzyme into normal chimpanzees (100 Μg) in the absence or presence of the thrombin inhibitor rec-hirudin (1.0 mg/kg loading dose plus 0.3 mg/kg body wt continuous infusion). Factor Xla elicited an immediate activation of factors IX, X, and prothrombin, as measured by their respective activation fragments. However, whereas the activation of factors IX and X was immediate and shortlasting, (peak increments of 6- and 1.4-fold of baseline at 5 minutes after injection), the conversion of prothrombin gradually increased, reaching a summit of 6-fold baseline values after 60 min, and remaining elevated during the course of the experiments. Thrombin-antithrombin complexes also remained elevated during the study period. In the presence of hirudin, the initial activation of factors IX, X, and prothrombin was unchanged, however the further increment in prothrombin fragment FI+2 was markedly inhibited. These results demonstrate that factor Xla is a potential agonist of the intrinsic cascade in vivo, which activity is enhanced in the presence of thrombin.

 

  • References

  • 1 Walsh PN. Factor XI: A renaissance. Sem Hematol 1992; 29: 189-201
    PubMedGoogle Scholar
  • 2 Di Scipio RG, Kurachi K, Davie EW. Activation of human factor IX (Christmas factor). J Clin Invest 1978; 61: 1528-1538
    CrossrefPubMedGoogle Scholar
  • 3 Østerud B, Bouma BN, Griffin JN. Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI. J Biol Chem 1978; 253: 5946-5951
    PubMedGoogle Scholar
  • 4 Lindquist PA, Fujikawa K, Davie EW. Activation of bovine factor IX (Christmas factor) by factor XIa (Activated plasma thromboplastin antecedent) and a protease from Russell’s viper venom. J Biol Chem 1978; 253: 1902-1909
    PubMedGoogle Scholar
  • 5 Walsh PN, Bradford H, Sinha D, Pipemo JR, Tuszynski GP. Kinetics of the factor XIa catalyzed activation of human blood coagulation factor IX. J Clin Invest 1984; 73: 1392-1399
    CrossrefPubMedGoogle Scholar
  • 6 Bolton-Maggs PHB, Young Wan-Yin B, McCraw AH, Slack J, Kemoff PBA. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988; 69: 521-528
    CrossrefPubMedGoogle Scholar
  • 7 Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325: 153-158
    CrossrefPubMedGoogle Scholar
  • 8 Gailani D, Broze Jr. GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-912
    CrossrefPubMedGoogle Scholar
  • 9 Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII: Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991; 266: 7353-7358
    CrossrefPubMedGoogle Scholar
  • 10 Scott CF, Colman RW. Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate. Proc Natl Acad Sci USA 1992; 89: 11189-11193
    CrossrefPubMedGoogle Scholar
  • 11 Brunnee T, La Porta C, Reddigari SR, Salerno VM, Kaplan AP, Silverberg M. Activation of factor XI in plasma is dependent on factor XII. Blood 1993; 81: 580-586
    PubMedGoogle Scholar
  • 12 Gailani D, Broze Jr. GJ. Factor XH-independent activation of factor XI in plasma: Effects of sulfatides on tissue factor- induced coagulation. Blood 1993; 82: 813-819
    PubMedGoogle Scholar
  • 13 von dem Borne PAK, Koppelman SJ, Bouma BN, Meijers JCM. Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen. Thromb Haemost 1994; 72: 397-402
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990; 76: 731-736
    CrossrefPubMedGoogle Scholar
  • 15 Bauer KA, Kass BL, ten Cate H, Bednarek MA, Hawiger JJ, Rosenberg RD. Detection of factor X activation in humans. Blood 1989; 74: 2007-2015
    PubMedGoogle Scholar
  • 16 Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the FI+2 fragment and thrombin- antithrombin complex. Blood 1982; 59: 1086-1096
    PubMedGoogle Scholar
  • 17 Boermeester MA, van Leeuwen PAM, Coyle SM, Houdijk AJP, Eerenberg AM, Wolbink GJ, Pribble JP, Stiles DM, Wesdorp RIC, Hack CE, Lowry SF. Interleukin-1 receptor blockade in patients with sepsis syndrome: evidence that interleukin-1 contributes to the release of interleukin-6, elastase and phospholipase A2, and to activation of the complement, coagulation and fibrinolytic system. Doctoral Thesis, University of Amsterdam, The Netherlands 1995; 169-194
    PubMedGoogle Scholar
  • 18 Gruber A, Griffin JH. Direct detection of activated protein C in blood from human subjects. Blood 1992; 79: 2340-2348
    CrossrefPubMedGoogle Scholar
  • 19 Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-10370
    CrossrefPubMedGoogle Scholar
  • 20 Kaplan AP, Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 1-15
    PubMedGoogle Scholar
  • 21 Levi M, Hack CE, de Boer JP, Brandjes DPM, Buller HR, ten Cate JW. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. J Clin Invest 1991; 88: 1155-1160
    CrossrefPubMedGoogle Scholar
  • 22 ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD. The activation of factor X and prothrombin by recombinant factor Vila in vivo is mediated by tissue factor. J Clin Invest 1993; 92: 1207-1212
    CrossrefPubMedGoogle Scholar
  • 23 Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Buller HR, van Deventer SJH, Hack CE, ten Cate JW, Rosenberg RD. Inhibition of endotoxin- induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93: 114-120
    CrossrefPubMedGoogle Scholar
  • 24 Teitel JM, Rosenberg RD. The protection of factor Xa from neutralization by the heparin-antithrombin complex. J Clin Invest 1983; 71: 1383-1391
    CrossrefPubMedGoogle Scholar
  • 25 Mann KG, Krishnaswamy S, Lawson JH. Surface-dependent hemostasis. Sem Hematol 1992; 29: 213-226
    PubMedGoogle Scholar
  • 26 Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor Vila in hemophilia A and B patients. Blood 1992; 80: 25-28
    PubMedGoogle Scholar
  • 27 Eichinger S, Mannucci PM, Tradati F, Arbini AA, Rosenberg RD, Bauer KA. Determinants of plasma factor Vila levels in humans. Blood 1994 84. abstract 946
    PubMedGoogle Scholar
  • 28 Wuillemin WA, Minnema M, Meijers JCM, Roem D, Eerenberg AJM, Nuijens JH, ten Cate H, Hack CE. Inactivation of factor XIa in human plasma assessed by measuring factor XIa- protease inhibitor complexes: major role for Cl - inhibitor. Blood 1995; 85: 1517-1526
    CrossrefPubMedGoogle Scholar
  • 29 Mannucci PM, Bauer KA, Santagostino E, Faioni E, Barzegar S, Coppola R, Rosenberg RD. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient persons. Blood 1994; 84: 1314-1319
    CrossrefPubMedGoogle Scholar